Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans-Reference-Cited by-同舟云学术

Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: Focus on the role and impact of proteoglycans

Published:2014-04 Issue: Volume:35 Page:182-193
ISSN:0945-053X
Container-title:Matrix Biology
language:en
Short-container-title:Matrix Biology

Author:

Skandalis Spyros S.,Afratis Nikolaos,Smirlaki Gianna,Nikitovic Dragana,Theocharis Achilleas D.,Tzanakakis George N.,Karamanos Nikos K.

Funder

European Union (European Social Fund — ESF)

Greek National Funds

Publisher

Elsevier BV

Subject

Molecular Biology

Reference187 articles.

1. Signaling regulation of genomic and nongenomic functions of estrogen receptors;Acconcia;Cancer Lett.,2006

2. Signalling by the type 1 insulin-like growth factor receptor: interplay with the epidermal growth factor receptor;Adams;Growth Factors,2004

3. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels;Adany;J. Biol. Chem.,1990

4. Glycosaminoglycans: key players in cancer cell biology and treatment;Afratis;FEBS J.,2012

5. Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation;Alexaki;FASEB J.,2004

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D bioprinted breast tumor-stroma models for pre-clinical drug testing;Materials Today Bio;2023-12

2. Anti–MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression;International Immunopharmacology;2023-11

3. Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway;American Journal of Physiology-Cell Physiology;2023-09-01

4. Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast Cancer─Design, Synthesis, and In Vitro Evaluation;ACS Omega;2023-08-23

5. Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer;Pharmacological Research;2023-07